The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2
出版年份 2012 全文链接
标题
The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2
作者
关键词
-
出版物
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Volume 28, Issue 1, Pages 65-77
出版商
Wiley
发表日期
2012-07-24
DOI
10.1111/j.1472-8206.2012.01071.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Characterization of Rhodamine-123 as a Tracer Dye for Use In In vitro Drug Transport Assays
- (2012) Samantha Forster et al. PLoS One
- Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics
- (2011) Atsushi Yonezawa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Characterization of rhodamine-123, calcein and 5(6)-carboxy-2′,7′-dichlorofluorescein (CDCF) export via MRP2 (ABCC2) in MES-SA and A549 cells
- (2011) Vesna Munić et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Profiling of a Prescription Drug Library for Potential Renal Drug–Drug Interactions Mediated by the Organic Cation Transporter 2
- (2011) Yasuto Kido et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of Human OCT1-Mediated Transport of DAPI as a Fluorescent Probe Substrate
- (2011) Tomoya Yasujima et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Drug Transporters and Imatinib Treatment: Implications for Clinical Practice
- (2010) K. Eechoute et al. CLINICAL CANCER RESEARCH
- Organic Cation Transporters Modulate the Uptake and Cytotoxicity of Picoplatin, a Third-Generation Platinum Analogue
- (2010) Swati S. More et al. MOLECULAR CANCER THERAPEUTICS
- Drug Uptake Systems in Liver and Kidney: A Historic Perspective
- (2009) B Hagenbuch CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Transport of Lamivudine [(-)- -L-2',3'-Dideoxy-3'-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3
- (2009) G. Minuesa et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Five Amino Acids in the Innermost Cavity of the Substrate Binding Cleft of Organic Cation Transporter 1 Interact with Extracellular and Intracellular Corticosterone
- (2009) C. Volk et al. MOLECULAR PHARMACOLOGY
- How DASPMI Reveals Mitochondrial Membrane Potential: Fluorescence Decay Kinetics and Steady-State Anisotropy in Living Cells
- (2008) Radhan Ramadass et al. BIOPHYSICAL JOURNAL
- Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor- or Interleukin-6
- (2008) M. L. Vee et al. DRUG METABOLISM AND DISPOSITION
- Nitric oxide down-regulates the expression of organic cation transporters (OCT) 1 and 2 in rat kidney during endotoxemia
- (2008) Suzanne Heemskerk et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Structural Requirements for Drug Inhibition of the Liver Specific Human Organic Cation Transport Protein 1
- (2008) Gustav Ahlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)
- (2008) Oliver Zolk et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started